CambridgeSoft

CambridgeSoft is a company that provides advanced discovery, collaboration, and knowledge management solutions through desktop software, scientific databases, and consulting services. Targeting the pharmaceutical, biotechnology, and chemical sectors, the company's offerings include enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery, and chemical research. Their flagship software suite, Chem & Bio Office, is an industry-standard communication tool for chemists, and Chem & Bio Office Enterprise extends this functionality to enable organizations to implement application and information solutions via Internet, intranet, and extranet technologies. Founded in 1986, CambridgeSoft primarily serves the pharmaceutical, biotechnology, and chemical industries, as well as the higher education, academic research, and government sectors. Their tools, including software, databases, and web platforms, enhance customers' capabilities to create, analyze, and share chemical, biological, and scientific information efficiently. In November 2009, the company received a significant $31.30M Venture Round investment from Goldman Sachs and Health Evolution Partners. With a focus on empowering scientific innovation and accelerating discovery and collaboration across research industries, CambridgeSoft continues to be a prominent player in the Enterprise Software and Pharmaceutical industries.